The CBD beverage market could be worth about $3 billion by 2025, according to analysts at Grand View Research. In fact, according to the firm, “Rising demand for wellness drinks is anticipated to drive the growth. Moreover, the low sugar content of the product and the presence of an appropriate quantity of cannabis for consumption … Continue reading Cannabis Beverage Stocks to Consider for 2022
On December 1, the Supreme Court granted Xebra Brands’ (CSE:XBRA) injunction that now positions the company has an outright first mover advantage in the Mexican CBD and CBG markets. It now authorizes it as the first in Mexico to legally cultivate hemp, and includes the right to commercialize hemp derived cannabinoids, such as CBD and … Continue reading Mexico’s Supreme Court Ruling Big News for Cannabis Company
The CBD infused product market could balloon to $165.7 billion, according to Meticulous Research at a CAGR of 48.1%. That’s already creating sizable opportunity for companies such as Pure Extracts Technologies Corp. (CSE:PULL)(OTC:PRXTF)(XFRA:A2QJAJ), Canopy Growth Corporation (NASDAQ:CGC)(TSX:WEED), Tilray Inc. (NASDAQ:TLRY), Charlotte’s Web Holdings Inc. (TSX:CWEB)(OTC:CWBHF), and cbdMD Inc. (NYSE:YCBD). “CBD-infused products are becoming increasingly popular. … Continue reading Catalysts Driving a $165.7 Billion CBD Opportunity
If Joe Biden were to win the election in November, here are some of the top stocks to consider. For one, according to The Wall Street Journal, expect to see turbulence in the stock market on a Biden win. As they note, Biden could potentially usher in increased regulation, and higher taxes, for example. “More … Continue reading What Could Happen if Joe Biden Wins U.S. Election
The psychedelics boom may be even more profitable than cannabis. Granted, such drugs have been written off for years. But that may not be the case for much longer. With many like LSD, MDMA, and psilocybin showing promise for treating a range of mental and health conditions, including obsessive-compulsive disorder, PTSD, opioid addiction, alcoholism, eating … Continue reading The Psychedelic Boom Could be Bigger than Cannabis
The cannabis story arguably had its most impressive year in 2018. But 2019 may be even better. With the 2018 Farm Bill, U.S. states pushing for legalization, corporate interest, Canadian approval and the CBD boom, cannabis stocks have significant upside potential. Even Cowen says U.S. cannabis sales alone could reach $80 billion by 2030 – … Continue reading Five Small-Cap Cannabis Stocks to Watch in March 2019
